Regulatory Rapporteur March 2019 | MEMBERS |
Meeting report: Addressing the impact of the EU Medical Devices Regulation on co | MEMBERS |
Does market size really matter? A regulator’s perspective | MEMBERS |
Meeting report: Accelerating anticancer agent development and validation (AAADV) | MEMBERS |
Applying for an EU marketing authorisation: a pharmacovigilance perspective | MEMBERS |
Tackling AMR - the role of veterinary medicine in Germany’s One Health approach | MEMBERS |
AMR: Is a paradigm shift needed in medicines regulation to combat bacterial infe | MEMBERS |